Repeated treatment with the selective kappa opioid agonist U-69593 produces a marked depletion of dopamine D2 receptors
- 1 November 1998
- Vol. 30 (3) , 275-283
- https://doi.org/10.1002/(sici)1098-2396(199811)30:3<275::aid-syn5>3.0.co;2-8
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Kappa opioid inhibition of morphine and cocaine self-administration in ratsBrain Research, 1995
- Direct in vivo evidence that D2 dopamine receptors can modulate dopamine uptakeNeuroscience Letters, 1994
- Comparative study of the effects of mu, delta and kappa opioid agonists on 3H-dopamine uptake in rat striatum and nucleus accumbensNeuropharmacology, 1994
- The kappa-opioid receptor agonist U-69593 attenuates cocaine-induced behavioral sensitization in the ratBrain Research, 1993
- Biphasic effect of D-2 agonist quinpirole on locomotion and movementsEuropean Journal of Pharmacology, 1989
- Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats.Proceedings of the National Academy of Sciences, 1988
- Obligatory D-1/D-2 receptor interaction in the generation of dopamine agonist related behaviorsEuropean Journal of Pharmacology, 1986
- Pharmacology in vivo of the phenylindan derivative, lu 19-005, a new potent inhibitor of dopamine, noradrenaline and 5-hydroxytryptamine uptake in rat brainNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1985
- Cocaine: Discussion on the Role of Dopamine in the Biochemical Mechanism of ActionPublished by Springer Nature ,1977
- Studies on the distinction between uptake inhibition and release of [3H]dopamine in rat brain tissue slicesBiochemical Pharmacology, 1975